October 23, 2003
The NAMI Policy Research Institute (NPRI) today announced creation of a Task Force on Serious Mental Illness Research, co-chaired by Edward Scolnick, MD, president emeritus of Merck Research Laboratories and NAMI medical director Ken Duckworth, MD, former mental health commissioner for Massachusetts.
The Executive Committee of NAMI's Scientific Council, chaired by Jack Gorman, MD, Chair of the Department of Psychiatry at Mount Sinai School of Medicine, will help coordinate the effort.
"NAMI takes seriously the statement of Dr. Thomas Insel, director of the National Institute for Mental Health (NIMH), that with the right investments, scientists are within reach of finding a cure for schizophrenia in the next ten years," said NAMI national executive director Richard C. Birkel, PhD. "The critical challenge is to set the right priorities for research investments and to insist that the clinical research enterprise translates readily into real world practice. In the long run these investments will mean both lives and money saved."
"Recent advances in biomedicine, including the decoding of the human genome, make possible a revolution in the treatment of psychiatric illnesses, a revolution that is already underway for other serious diseases," Scolnick said. "The fact that we have the knowledge and tools to develop newer, better-targeted medication for illnesses like schizophrenia and bipolar disorder, with fewer side effects, demands that we make the appropriate research investments. The mission of the task force is to help provide a roadmap for that revolution."
"We also must invest in research that will make the effective interventions already achieved, along with those still to come, available to every individual with a serious mental illness as quickly as possible," said Duckworth.
NIMH, the main federal agency responsible for funding research on serious mental illnesses -- with a budget of more than $ 1.3 billion in fiscal year 2003 -- will be the focus of the task force's work.
"Given the unprecedented research opportunities that exist today, it is essential that NIMH use all of its resources wisely to expedite treatment advances in serious mental illness," said Gorman.
--------
Source: National Alliance for the Mentally Ill
Answer by phulcrum229
I just love how everyone expects, and want's a magic pill to cure the ails of the world. especially using information in genome mapping, look with most psychological disorders including Schizophrenia, most if not all of the condition is fueled by the person's beliefs and perceptions of the experience they are having. anything that is affecting someone's perception of reality is shaped by what they believe it is. Yes the experience is real for the person going through the condition, and I am in no detracting what they are either seeing or hearing is real, but it is only as real as they give credence to it.
Having gone through it and come out of it, I know this to be true.
having experiences with current medications while learning to manage it without. I do not think anything of worth comes easy, but is hard fought for, and earned.
this is prolly the worst answer to your question but there is truth here. and weather someone or no one sees it. at this point who cares.
but learning to live with the condition and properly manage it is the closest we as a species are going to get to a cure without manipulating the human genome,( and yes Gatica comes to mind here)
but to shed some light out there to those who have it and suffer, there is hope if you only find the strength to look within and search for the truth...
Hi,I did the following:
Interview on Employment For All TV Show -- Part 1
Access information and advice on a wide range of mental health issues including conditions and disorders including stress and depression, therapy
Orignal From: Cure for Schizophrenia by National Alliance for Mentally ill Can this be True?
No comments:
Post a Comment